Compare H2O America (HTO) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
H2O America vs Immunovant Inc. Common Stock — how do they compare? H2O America trades at $58.54 (market cap $2.43B), while Immunovant Inc. Common Stock trades at $30.5 (market cap $6.25B). The key difference: Immunovant Inc. Common Stock is far larger — about 2.6× H2O America's market cap, and H2O America pays a 3.03% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold H2O America for 40 Days and Immunovant Inc. Common Stock for 1 Days on average.
| HTO | IMVT | |
|---|---|---|
Market Cap | $2.43B | $6.25B |
Volume | 593,883 | 1,755,411 |
Sector | Utilities | Health |
52-Week High | $65.43 | $44.96 |
52-Week Low | $44.44 | $17.03 |
Typical Hold Time | 40 Days | 1 Days |
Enterprise Value | $4.22B | $5.35B |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HTO trades at $58.70, up 1.24% with mixed technical signals showing bearish moving averages but bullish oscillators. The company maintains strong profitability with 12.91% net margins and recently completed the Quadvest acquisition through its Texas subsidiary. Analyst consensus remains strongly bullish with 83% buy ratings and a $66.50 price target, representing 13% upside potential from current levels.
The outlook appears favorable given the strategic acquisitions and Dividend King status, though execution risks from recent equity dilution and negative cash flow from investing activities warrant monitoring. The stock offers value with reasonable P/E of 20.45 and consistent earnings beats, supported by institutional accumulation including BlackRock's significant position.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About H2O America
H2O America is a utility company that provides essential water and wastewater services, primarily in the United States. The company operates a network of regulated water and wastewater systems, focusing on responsible resource management and high-quality service delivery. HTO aims to expand its operational footprint through acquisitions and internal growth, serving residential, commercial, and industrial customers.
Read more on HTO →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
